Emerald Oil Inc (EOX) Jumps 19.23% on January 21

Equities Staff |

Emerald Oil Inc (EOX) was among the biggest gainers on the Russell 2000 for Thursday January 21 as the stock popped 19.23% to $0.67, representing a gain of $0.1077 per share. Some 162,539 shares traded hands on 387 trades, compared with an average daily volume of 309,877 shares out of a total float of 8.71 million. The stock opened at $0.57 and traded with an intraday range of $0.69 to $0.57.

After today's gains, Emerald Oil Inc reached a market cap of $5.82 million. Emerald Oil Inc has had a trading range between $26.00 and $0.39 over the last year, and it had a 50-day SMA of $1.33 and a 200-day SMA of $4.19.

Emerald Oil Inc is an independent exploration and production company. The Company is engaged in acquiring acreage and developing oil and natural gas wells in the Williston Basin of North Dakota and Montana.

Emerald Oil Inc is based out of Denver, CO and has some 42 employees. Its CEO is McAndrew Rudisill.

For a complete fundamental analysis analysis of Emerald Oil Inc, check out Equities.com’s Stock Valuation Analysis report for EOX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

Spotify

Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…